5- other GLP-1 trials in Parkinsons have been statistically negative or the results unclear, 6- the study was conducted in only very early Parkinsons cases, 7- the data, if replicable, may not be generalizable to all GLP-1 agonist drugs or to all subtypes of Parkinsons, and 8- the drug Lixisenatide requires a DAILY injection
GHK-Cu is the copper-bound form of GHK, which is used in research to study peptidecopper interactions and related signaling behavior
As proof of concept, bariatric surgery has been associated with a decreased prevalence of obesity-related cancers, including PDAC, illustrating the key role of weight management for cancer prevention 3,4
With a slope between Choquequirao and the beach of San Ignacio (1500 m.a.s.l.), deep
L-Carnitina em P Ca
Of note, the evidence for people with type 2 diabetes and CKD is more robust for SGLT-2 inhibitors, given that dedicated cardiorenal outcome trials have consistently demonstrated significant cardiorenal protection in this subpopulation